Artificial Intelligence–Based Radiotherapy Contouring and Planning to Improve Global Access to Cancer Care
-
Published:2024-04
Issue:10
Volume:
Page:
-
ISSN:2687-8941
-
Container-title:JCO Global Oncology
-
language:en
-
Short-container-title:JCO Glob Oncol
Author:
Court Laurence E.1ORCID, Aggarwal Ajay2ORCID, Jhingran Anuja1ORCID, Naidoo Komeela3ORCID, Netherton Tucker1ORCID, Olanrewaju Adenike1ORCID, Peterson Christine1ORCID, Parkes Jeannette4ORCID, Simonds Hannah3ORCID, Trauernicht Christoph3ORCID, Zhang Lifei1, Beadle Beth M.5ORCID, , Ahmad Shareen, Anderson David, Baghwala Arjig, Chan Karen, Das Prajnan, Edwards Albert, Elbanna May, Elhalawani Hesham, Elsayed Medhat, Ewongwo Agnes, Fakie Nazia, Fuller C. David, Garden Adam, Gove Matt, Guerrero-Urbano Teresa, Kaittany Njeri, Khan Mishal, Langer Joshua, Leeig Percy, Lee Becky, Lee Anna, Lee Belinda, Leech Michelle, Li Ben, Lichter Katie, Lin Lilie, Lin Stacy, Lombe Dorothy, Mallick Indranil, Maroongroge Sean, Martin Rachael, McGinnis Gwendolyn, Mezera Megan, Mohammedsaid Mustefa, Nguyen Son, Nuanjing Jenny, Phillips Tony, Prajapati Surendra, Punt Lydia, Reed Valerie, Roniger Dominique, Shaitelman Simona, Sherriff Alicia, Shiao Jay, Skinner Heath, Susan Ashely, Sutton Jordan, Syed Hamza, Thang Sandy, Thompson Juanita, Walker Gary, Wetter Julie, White Ingrid, Xu Melody, Yousif Yousif, Zhu Simeng
Affiliation:
1. University of Texas MD Anderson Cancer Center, Houston, TX 2. Guy's and St Thomas Hospitals, London, United Kingdom 3. Stellenbosch University, Stellenbosch, South Africa 4. University of Cape Town, Cape Town, South Africa 5. Stanford University, Stanford, CA
Abstract
PURPOSE Increased automation has been identified as one approach to improving global cancer care. The Radiation Planning Assistant (RPA) is a web-based tool offering automated radiotherapy (RT) contouring and planning to low-resource clinics. In this study, the RPA workflow and clinical acceptability were assessed by physicians around the world. METHODS The RPA output for 75 cases was reviewed by at least three physicians; 31 radiation oncologists at 16 institutions in six countries on five continents reviewed RPA contours and plans for clinical acceptability using a 5-point Likert scale. RESULTS For cervical cancer, RPA plans using bony landmarks were scored as usable as-is in 81% (with minor edits 93%); using soft tissue contours, plans were scored as usable as-is in 79% (with minor edits 96%). For postmastectomy breast cancer, RPA plans were scored as usable as-is in 44% (with minor edits 91%). For whole-brain treatment, RPA plans were scored as usable as-is in 67% (with minor edits 99%). For head/neck cancer, the normal tissue autocontours were acceptable as-is in 89% (with minor edits 97%). The clinical target volumes (CTVs) were acceptable as-is in 40% (with minor edits 93%). The volumetric-modulated arc therapy (VMAT) plans were acceptable as-is in 87% (with minor edits 96%). For cervical cancer, the normal tissue autocontours were acceptable as-is in 92% (with minor edits 99%). The CTVs for cervical cancer were scored as acceptable as-is in 83% (with minor edits 92%). The VMAT plans for cervical cancer were acceptable as-is in 99% (with minor edits 100%). CONCLUSION The RPA, a web-based tool designed to improve access to high-quality RT in low-resource settings, has high rates of clinical acceptability by practicing clinicians around the world. It has significant potential for successful implementation in low-resource clinics.
Publisher
American Society of Clinical Oncology (ASCO)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|